Anticancer Therapies – Products

Publication of a research article by OSU investigators demonstrate that LOR-2040, improves the anticancer effects of the chemotherapy drug Ara-C.

Publication of a research article by OSU investigators demonstrate that LOR-2040, improves the anticancer effects of the chemotherapy drug Ara-C.

This new catalog of unusual amino acids for peptide synthesis includes over 350 high purity amino acid analogs, substituted amino acids, beta-homo amino acids, pseudoproline dipeptides, products for stapled peptides, glyco-amino acids, peptide nucleic acid (PNA) monomers and amino-PEG acids that can be incorporated into peptide products to enhance their pharmaceutical characteristics.

Test aims to identify FLT3 positive AML patients for specific use in connection with the Novartis development compound, midostaurin (PKC412).

Collaboration and licensing partners fund efforts in local and systemic administration of Company's novel delivery systems.

Molecular Profiles announces the continued expansion of its manufacturing capabilities with the recent purchase of the Xcelodose 120S system. The purchase of this system reflects the company's broader mission to expand the breadth and flexibility of its service offerings.

The purchase of the unique system reflects the company’s broader mission to expand the breadth and flexibility of its service offerings.

First UK Novalis Tx™ radiosurgery launched for treating cancer patients offers the possibility to perform precise painless treatment to tumours in a single patient visit.

Eisai assembles a team of oncology-focused liaisons to oversee each major market area in Japan along with 1,400 medical reps to promote and detail the oncology drug.

Amsbio's Screen Quest™ Calcium Assay kit provides a homogeneous fluorescence-based assay for detecting intracellular calcium mobilisation across a broad spectrum of biological targets.